KT (KT) Stock Price & Analysis
KT (KT) rose 1.64% to USD 18.56 as of July 25, 2026 at 03:08 UTC, according to Nexqual real-time market data.
KT last closed at USD 18.26; the session ranged USD 18.45–18.58 on volume of 1,101,928 shares. Market capitalization is $8.84B, with a 52-week range of USD 17.13–24.58 (NYQ). Source: Nexqual, July 25, 2026 at 03:08 UTC.
Key Statistics (as of July 25, 2026 at 03:08 UTC)
| Price | USD 18.56 |
|---|---|
| Change | ▲ 1.64% (up) |
| Previous Close | USD 18.26 |
| Open | USD 18.45 |
| Day Range | USD 18.45 – 18.58 |
| 52-Week Range | USD 17.13 – 24.58 |
| Volume | 1,101,928 shares |
| Market Cap | $8.84B |
| Exchange | NYQ |
Technical Analysis (KT)
Nexqual's technical model rates KT "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 03:08 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 60.27 (neutral) |
| vs SMA50 | Above (USD 18.21) |
| MACD | -0.06 (negative) |
Analyst Ratings (KT)
Wall Street analysts rate KT "None" based on 4 analysts, with a mean price target of USD 22.79 (range USD 20.1–26), per Nexqual as of July 25, 2026 at 03:08 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 22.79 |
| High Target | USD 26 |
| Low Target | USD 20.1 |
| Buy / Hold / Sell | 1 / 3 / 0 |
Earnings (KT)
| Next Earnings Date | 2026-08-10 |
|---|---|
| Revenue Estimate | $6.85T |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Financials & Fundamentals (KT)
| Total Revenue | $28.18T |
|---|---|
| Revenue Growth (YoY) | -1.00% |
| Gross Margin | +100.00% |
| Operating Margin | +7.05% |
| Profit Margin | +5.48% |
| ROE | +8.65% |
| Debt / Equity | 63.28 |
| Current Ratio | 1.15 |
| Total Cash | $4.71T |
| Total Debt | $12.65T |
| Free Cash Flow | $1.29T |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Financial Health Score (KT)
Nexqual rates KT's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:08 UTC.
| Growth | Strong — Revenue +52% YoY (annual) |
|---|---|
| Profitability | Mixed — Operating margin 7% |
| Balance Sheet | Solid — $4.71T cash vs $12.65T debt |
| Cash Flow | Mixed — FCF $1.29T, slim 4.6% margin |
| Efficiency | Mixed — ROE 9%, ROA 3.3% |
Ownership (KT)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +33.77% |
| Shares Outstanding | 476.26M |
| Float | 427.48M |
| Short % of Float | +1.35% |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Leadership (KT)
KT is led by Yoon-Young Park (age 63), CEO & Inside Director, per Nexqual as of July 25, 2026 at 03:08 UTC.
| CEO & Inside Director | Yoon-Young Park (age 63) |
|---|---|
| Senior Executive Vice President of Tech. Innovation Group | Seung-Phil Oh (age 55) |
| Senior Executive Vice President of Corporate Management Group | Hyun-Kyu Lim (age 61) |
| Senior Executive Vice President of Legal Affairs Office | Young-Bok Lee (age 64) |
| Executive Vice President | Eui-Jeung Choo (age 49) |
Major Backers & Investors (KT)
Notable institutional backers of KT include Wellington Management, Price (T.Rowe) Associates Inc, New World Fund Inc, according to Nexqual as of July 25, 2026 at 03:08 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Wellington Management | 4.55% |
| Price (T.Rowe) Associates Inc | 2.99% |
| New World Fund Inc | 2.63% |
| Capital International Investors | 2.02% |
| Niatross Investments Ltd | 1.84% |
| Pzena Investment Management LLC | 1.42% |
| JPMorgan | 1.42% |
| Robeco Institutional Asset Management B.V. | 1.15% |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SKM | SK Telecom Co., Ltd. | USD 35.67 | ▲ 5.1% |
| TIMB | TIM S.A. | USD 21.3 | ▼ 3.27% |
| KB | KB Financial Group Inc | USD 117.43 | ▼ 1.27% |
| VIV | Telefonica Brasil S.A. | USD 14.05 | ▲ 0.07% |
| KEP | Korea Electric Power Corporatio | USD 12.06 | ▲ 1.6% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:08 UTC. This page is informational and not investment advice.